U.S. stock futures rise on increased rate cut optimism; Dell’s outlook impresses
SANTA CLARA - Agilent Technologies, Inc. (NYSE:A) reported fourth-quarter revenue of $1.86 billion, representing 9.4% growth year-over-year, while adjusted earnings per share rose 9% to $1.59.
Despite the strong results, shares fell 1.4% following the report.
The laboratory equipment maker posted solid growth across all segments, with its Life Sciences and Diagnostics Markets Group leading the way with a 15% revenue increase to $755 million. The company’s adjusted net income reached $452 million for the quarter, up from $418 million in the same period last year.
"We enter FY26 with confidence and momentum. Agilent is uniquely positioned to lead in life-sciences and diagnostics for years to come," said Agilent President and CEO Padraig McDonnell.
For the full fiscal year 2025, Agilent reported revenue of $6.95 billion, representing 6.7% growth YoY, with adjusted earnings of $5.59 per share, up 6% from fiscal 2024.
Looking ahead, the company provided fiscal 2026 revenue guidance of $7.3 billion to $7.4 billion, representing growth of 5% to 7%, with adjusted EPS expected between $5.86 and $6.00. For the first quarter of fiscal 2026, Agilent expects revenue between $1.79 billion and $1.82 billion, with adjusted EPS of $1.35 to $1.38.
The Agilent CrossLab Group reported fourth-quarter revenue of $755 million, up 7% YoY, while the Applied Markets Group saw revenue increase 4% to $351 million. The company’s performance was driven by its customer-focused approach and unified commercial organization, which McDonnell noted "continue to unlock operating efficiencies, fuel innovation, enhance commercial execution, and create long-term value."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.